Helix BioPharma Corp. (HBP) — Net Asset Quality Index
Helix BioPharma Corp. (HBP) has a Net Asset Quality Index of 82.9% as of January 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$18.52 Million minus total liabilities of CA$3.16 Million yields net assets of CA$15.36 Million. A higher index indicates a stronger, lower-leverage balance sheet. See HBP defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Helix BioPharma Corp. Net Asset Quality Index Over Time (2007–2025)
This chart shows how Helix BioPharma Corp.'s Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of January 2026, the index stands at 82.9%, representing net assets of CA$15.36 Million against total assets of CA$18.52 Million CAD. Explore HBP cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Helix BioPharma Corp. (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Helix BioPharma Corp. from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HBP market cap.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.9% | CA$15.59 Million | CA$18.80 Million | CA$3.22 Million | ▲ +88.9 pp |
| 2024 | -6.0% | CA$-90.00K | CA$1.49 Million | CA$1.58 Million | ▲ +76.0 pp |
| 2023 | -82.0% | CA$-844.00K | CA$1.03 Million | CA$1.87 Million | ▼ -90.6 pp |
| 2022 | 8.6% | CA$319.00K | CA$3.73 Million | CA$3.41 Million | ▲ +42.8 pp |
| 2021 | -34.3% | CA$-1.39 Million | CA$4.07 Million | CA$5.46 Million | ▼ -95.0 pp |
| 2020 | 60.8% | CA$2.98 Million | CA$4.91 Million | CA$1.93 Million | ▲ +409.8 pp |
| 2019 | -349.0% | CA$-3.28 Million | CA$940.00K | CA$4.22 Million | ▼ -215.9 pp |
| 2018 | -133.1% | CA$-1.53 Million | CA$1.15 Million | CA$2.67 Million | ▼ -132.4 pp |
| 2017 | -0.8% | CA$-17.00K | CA$2.19 Million | CA$2.20 Million | ▼ -71.6 pp |
| 2016 | 70.8% | CA$3.16 Million | CA$4.47 Million | CA$1.30 Million | ▼ -16.8 pp |
| 2015 | 87.6% | CA$6.83 Million | CA$7.80 Million | CA$969.00K | ▲ +0.8 pp |
| 2014 | 86.7% | CA$6.81 Million | CA$7.85 Million | CA$1.04 Million | ▲ +2.9 pp |
| 2013 | 83.8% | CA$4.92 Million | CA$5.87 Million | CA$948.00K | ▲ +2.1 pp |
| 2012 | 81.7% | CA$6.22 Million | CA$7.62 Million | CA$1.39 Million | ▼ -9.0 pp |
| 2011 | 90.7% | CA$22.11 Million | CA$24.37 Million | CA$2.26 Million | ▲ +3.7 pp |
| 2010 | 87.0% | CA$15.76 Million | CA$18.11 Million | CA$2.35 Million | ▼ -1.3 pp |
| 2009 | 88.3% | CA$17.06 Million | CA$19.32 Million | CA$2.26 Million | ▼ -6.4 pp |
| 2008 | 94.7% | CA$20.52 Million | CA$21.67 Million | CA$1.14 Million | ▲ +5.5 pp |
| 2007 | 89.2% | CA$12.73 Million | CA$14.27 Million | CA$1.54 Million | — |